MAPT and Alzheimer disease: Similarly, phosphorylation levels at Ser396/Ser404, which comprise one of the earliest AD-related abnormal tau processing events (56), were 31.1% higher in CREB3L2-ATF4 neurons as detected with the PHF-1 antibody (Fig. 6D) (57, 58).